Skip to main content
. 2009 Apr;174(4):1390–1399. doi: 10.2353/ajpath.2009.080841

Figure 4.

Figure 4

A: Effects of different ratios and doses of β-ligands on phosphorylated STAT1, STAT4, and STAT6 levels in the mouse Con A hepatitis model. Treatments A–M are specified in Table 1. B: Effects of different ratios and doses of β-ligands on NKT lymphocyte distribution in the mouse Con A hepatitis model. FACS analysis was preformed for CD3/NK1.1 surface markers on lymphocytes in the spleen and in the liver.